Data Management and Analysis to Enhance the DEA Diversion Program

Cover sheet of DEA White paperData Management and Analysis to Enhance the Drug Enforcement Agency Diversion Program

Drug diversion is a common practice tied closely to the extensive opioid epidemic problem that faces our country today. The Drug Enforcement Administration (DEA) is charged with the daunting task of ensuring that properly and legally manufactured drugs are distributed and managed in a manner that ensure that they are provided by the intended distributers to their
properly prescribed patients. As part of that effort, DEA executes criminal and administrative warrants to seize or acquire medical records from doctor’s offices and pharmacy records from pharmacies as evidence of violations of the Controlled Substance Act. Click to continue reading the white paper.


Let's Talk About Solutions

How can Qlarant help you improve quality and program performance?